
Ministers have been urged to open up access for scientists to psilocybin, the chemical compound in magic mushrooms, to allow research into its potential therapeutic benefits.
Psilocybin, a Class A drug and a psychedelic, is currently being trialled as an alternative treatment to several mental illnesses including depression, anorexia and addiction.